Hypertension after renal transplantation

Area of Science:

• Nephrology
• Cardiology
• Immunology

Background:

• Hypertension affects nearly 90% of renal graft recipients under current immunosuppression.
• Causes include impaired renal function, calcineurin inhibitors, renin secretion, transplant artery stenosis, polycythemia, and donor genetics.
• Even mild blood pressure elevation significantly impacts recipient and graft survival by increasing vascular injury.

Purpose of the Study:

• To review the causes and management of hypertension in renal transplant recipients.
• To highlight the importance of systolic blood pressure and circadian blood pressure profiles.
• To discuss current and recommended antihypertensive treatment strategies.

Main Methods:

• Literature review of causes of hypertension post-renal transplantation.
• Analysis of the impact of blood pressure on graft and recipient survival.
• Evaluation of current and proposed antihypertensive treatment guidelines.

Main Results:

• Multiple factors contribute to hypertension, including allograft nephropathy, immunosuppressants, and vascular issues.
• Elevated systolic blood pressure and abnormal circadian patterns are particularly detrimental.
• Angiotensin converting enzyme inhibitors are now indicated, alongside diuretics and calcium channel blockers.

Conclusions:

• Effective blood pressure management is crucial for renal allograft recipient and graft survival.
• Diuretics and calcium channel blockers remain foundational therapies.
• Angiotensin converting enzyme inhibitors play a role in managing hypertension in this population.